Pronounced antibody elevation after SARS-CoV-2 BNT162b2 mRNA booster vaccination in nursing home residents.

Yong ChongTakeyuki GotoNaoki TaniAkiko YonekawaHideyuki IkematsuNobuyuki ShimonoYosuke TanakaKoichi Akashi

Published in: Influenza and other respiratory viruses (2022)

Advanced aged nursing home residents, poor responders in the initial SARS-CoV-2 vaccine series, could obtain sufficient antibody responses with the additional booster dose, despite more than 6 months after the second.

Keyphrases

sars cov
respiratory syndrome coronavirus
binding protein
coronavirus disease